Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia.
about
Drugging the unfolded protein response in acute leukemiasEndoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseasesThe unfolded protein response in immunity and inflammationThe burden of trisomy 21 disrupts the proteostasis network in Down syndrome.The mammalian tRNA ligase complex mediates splicing of XBP1 mRNA and controls antibody secretion in plasma cellsCleavage of BLOC1S1 mRNA by IRE1 Is Sequence Specific, Temporally Separate from XBP1 Splicing, and Dispensable for Cell Viability under Acute Endoplasmic Reticulum StressA Covalent Cysteine-Targeting Kinase Inhibitor of Ire1 Permits Allosteric Control of Endoribonuclease Activity.X-Box-Binding Protein 1 and Innate Immune Responses of Human Cystic Fibrosis Alveolar Macrophages.Deregulated expression of the HSP40 family members Auxilin-1 and -2 is indicative of proteostasis imbalance and predicts patient outcome in Ph(+) leukemia.Mcl-1 downregulation leads to the heightened sensitivity exhibited by BCR-ABL positive ALL to induction of energy and ER-stress.Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia.Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemiaCellular mechanisms of endoplasmic reticulum stress signaling in health and disease. 1. An overview.Novel Gene and Network Associations Found for Acute Lymphoblastic Leukemia Using Case-Control and Family-Based Studies in Multiethnic Populations.Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells.WNT16-expressing Acute Lymphoblastic Leukemia Cells are Sensitive to Autophagy Inhibitors after ER Stress Induction.Endoplasmic reticulum proteostasis: a key checkpoint in cancer.Targeting the unfolded protein response in cancer.The Unfolded Protein Response: At the Intersection between Endoplasmic Reticulum Function and Mitochondrial BioenergeticsThe Unfolded Protein Response in the Immune Cell Development: Putting the Caretaker in the Driving Seat.Valosin-Containing Protein/p97 as a Novel Therapeutic Target in Acute Lymphoblastic Leukemia.Targeting protein quality control pathways in breast cancer.In vitro efficacy of a first-generation valosin-containing protein inhibitor (CB-5083) against canine lymphoma.TUSC3: functional duality of a cancer gene.Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia.Inhibition of the NEDD8 conjugation pathway induces calcium-dependent compensatory activation of the pro-survival MEK/ERK pathway in acute lymphoblastic leukemia.Unfolded Protein Response of the Endoplasmic Reticulum in Tumor Progression and Immunogenicity.Driving Cancer Tumorigenesis and Metastasis Through UPR Signaling.3' enhancers hs3b/hs4 are dispensable for deregulation in mouse plasmacytomas with T(12;15) translocationsInterplay Between the Unfolded Protein Response and Immune Function in the Development of Neurodegenerative Diseases
P2860
Q26801114-92F080C2-5A26-44B7-AD15-EFE44CA8A6C2Q27027733-17D267CB-5336-4531-BA89-F8D8DADBA2AFQ29248713-9A36360D-35B1-44A8-BD23-D546EC966136Q33590361-590192C0-21A7-4AFB-92A3-A43EB2B687CDQ34807567-ECF8AC20-FB07-4DC3-A425-84A4FD3BD48FQ35626096-CC818290-2668-40F8-AE99-88796F4B0F74Q35899544-73818DF6-FBC3-47C9-85EC-E84E9893F582Q36516884-7330511A-21ED-4689-9D98-32C32E8927A3Q36560517-5EDB6D32-41CD-44C8-91BF-0EF3D8DC55DDQ36665287-5902850A-F494-4885-AF08-D3DF6007E638Q37109858-CB96A2C7-9CA4-4B39-B577-10AD81B002A5Q37702652-E6ED418B-DC3A-4BCB-8527-6484AB17BF9BQ38241810-DF3BD1D0-E985-4B97-B460-986BAAA76888Q38650702-368F5BA6-0FC3-4F3B-B4BD-95B2B48533CCQ38788154-83EA3FF0-044A-4F50-8E1B-39505F75D51FQ38845318-F0DF8D7E-6973-458A-A097-575ED9BF43C4Q39011260-F3055E8C-0D34-4C90-AF88-00E95A8B2DB2Q39232751-9F434065-2DB6-48EA-B636-642ADAAE8BA8Q39249695-FDBE31D5-8A68-40DD-8D32-391DAF2C24D6Q39431986-1BF414BA-DF38-4D37-A1C5-B7401E1FBB77Q41563447-9FAA0140-28B7-43D2-AAC6-CC823CD87B78Q46087491-F3DBA7F5-4D0C-4A14-99E7-36E663D0447AQ47219014-663DA251-7D83-4672-A613-81C8306C5454Q47774283-07EAA44A-0C9D-4EAB-8920-CA7243E79A4BQ47783708-3EFE9858-3752-41A1-BA36-F20D03BB3D55Q49787961-6D811501-43AA-48FC-8597-9E1592DAD6D4Q50073383-E5FFFB8E-5A63-4470-99CE-0AA4FB4A2A19Q50528588-A2B11AD8-B016-4967-B5C6-BB3844AD6870Q57818341-2433221E-62DE-4A28-815E-AEDFEFA3CB6AQ59132127-53A3A3FB-BE71-4723-8E99-4733F99BECEF
P2860
Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mechanistic rationale for targ ...... acute lymphoblastic leukemia.
@ast
Mechanistic rationale for targ ...... acute lymphoblastic leukemia.
@en
type
label
Mechanistic rationale for targ ...... acute lymphoblastic leukemia.
@ast
Mechanistic rationale for targ ...... acute lymphoblastic leukemia.
@en
prefLabel
Mechanistic rationale for targ ...... acute lymphoblastic leukemia.
@ast
Mechanistic rationale for targ ...... acute lymphoblastic leukemia.
@en
P2093
P2860
P356
P1476
Mechanistic rationale for targ ...... acute lymphoblastic leukemia.
@en
P2093
Aaron C Logan
Ari M Melnick
Behzad Kharabi Masouleh
Christian Hurtz
Chuanxin Huang
Huimin Geng
Lai N Chan
Markus Müschen
Mi Sook Chang
P2860
P304
P356
10.1073/PNAS.1400958111
P407
P577
2014-05-12T00:00:00Z